Skip to content
Disclosery

WELLS FARGO & COMPANY/MN: DRUG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of WELLS FARGO & COMPANY/MN on DRUG, newest first. How the timeline and the estimate are built.

WELLS FARGO & COMPANY/MN held 6,761 DRUG shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 6,761 shares
    Change vs previous 13F +4,229 shares

    <0.01% of the 13F portfolio, value $474,622.

    13F-HR 0000072971-26-000304 filed by WELLS FARGO & COMPANY/MN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 2,532 shares
    Change vs previous 13F -2,991 shares

    <0.01% of the 13F portfolio, value $184,760.

    13F-HR/A 0000072971-26-000285 filed by WELLS FARGO & COMPANY/MN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 5,523 shares
    Change vs previous 13F +2,697 shares

    <0.01% of the 13F portfolio, value $431,015.

    13F-HR 0000072971-26-000123 filed by WELLS FARGO & COMPANY/MN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,826 shares
    Change vs previous 13F +448 shares

    <0.01% of the 13F portfolio, value $171,425.

    13F-HR 0000072971-25-000256 filed by WELLS FARGO & COMPANY/MN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,378 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $62,090.

    13F-HR 0000072971-25-000214 filed by WELLS FARGO & COMPANY/MN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).